Condition: Immunotherapy · Sponsor: The Affiliated Hospital of Xuzhou Medical University
This is an experimental study to evaluate the safety and efficacy of CAR T cells targeting CAIX in the treatment of advanced renal cancer.
This description comes directly from the study's public registry record.
Hailong Li, M.D/Ph.D · 0086-17798835021 · Justinlee719@163.com
Qing Zhang, Ph.D · 0086-516-83262238 · qingzhang@xzhmu.edu.cn
Always discuss trial participation with your own doctor first.
| Affiliated Hospital of Xuzhou Medical University | Xuzhou, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04969354